Literature DB >> 24463677

Women's health, pregnancy, and the U.S. Food and Drug Administration.

Rebekah E Gee1, Susan F Wood, Kathryn G Schubert.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24463677     DOI: 10.1097/AOG.0000000000000063

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  4 in total

1.  Designing drug trials: considerations for pregnant women.

Authors:  Jeanne S Sheffield; David Siegel; Mark Mirochnick; R Phillips Heine; Christine Nguyen; Kimberly L Bergman; Rada M Savic; Jill Long; Kelly E Dooley; Mirjana Nesin
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

2.  The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.

Authors:  Merina Elahi; Noha Eshera; Nkosazana Bambata; Helen Barr; Beverly Lyn-Cook; Julie Beitz; Maria Rios; Deborah R Taylor; Marilyn Lightfoote; Nada Hanafi; Lowri DeJager; Paddy Wiesenfeld; Pamela E Scott; Emmanuel O Fadiran; Marsha B Henderson
Journal:  J Womens Health (Larchmt)       Date:  2016-02-12       Impact factor: 2.681

Review 3.  Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies.

Authors:  Flavia Franconi; Ilaria Campesi; Delia Colombo; Paola Antonini
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

4.  Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.

Authors:  Angela Colbers; Mark Mirochnick; Stein Schalkwijk; Martina Penazzato; Claire Townsend; David Burger
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.